Telotristat and Somatostatin Analogue in Advanced Neuroendocrine Tumors

Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School explains whether or not somatostatin analogues were needed to see efficacy in treatment for carcinoid syndromes. This was recorded ... Author: NCCN2017 Added: 03/31/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts